Coagulation disorders during treatment with cefazolin and rifampicin: rare but dangerous
<p>We describe a 79-year-old man with spondylodiscitis and unknown pathogen, treated with cefazolin and rifampicin. He developed a massive digestive hemorrhage. Prothrombin time was prolonged with severe vitamin-K-dependent clotting-factor deficiency. Severe bleeding can occur during cefazolin...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Copernicus Publications
2021-04-01
|
Series: | Journal of Bone and Joint Infection |
Online Access: | https://jbji.copernicus.org/articles/6/131/2021/jbji-6-131-2021.pdf |